- virus entry (endocytosis)
- virus replication and transcription (DMV)
- virus assembly (Golgi complex)
ASD-CoV is a novel formulation of intestinally absorbed oral alpha-cyclodextrin (CoM pat. pend.). ASD-CoV is a natural product that lowers the level of the initial infection to the level of a vaccination.
ASD-CoV reduces the serum phospholipids needed during the life cycle of coronaviruses, incl. SARS-CoV-2, which causes COVID-19:
ASD-CoV can be brought to marked within weeks under an NDIN and is safe enough to be taken before an infection has occured. A potential side effect is a slight reduction of body weight from the excretion of the lipids.
In contrast to hydroxychloroquine, which not only blocks the (heart) ACE2 receptor (below), but also inhibits autophagy (the essential cellular "detoxification"), ASD-CoV improves autophagy, whose decline is also involved in the etiology of many age-related diseases, including neuro-degenerative diseases, such as Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), see the AGING tab.
See the PAPERS tab for CoV-related publications and media.